Willing to Win ReaderThe podcast in writing. Sorted by your situation, and every conversation to read.

Willing to Win Reader

What biotech leaders did in your situation.

Standing on the shoulders of giants.

The conversations on Willing to Win, sorted by the situation you are in. Not by guest, not by episode. Each page holds what the people who were there said about it: how it felt, what they did the next morning, what came of it, and what to do this week. In their words.

Pick the one you are in. Below that, every conversation on its own, to read in full or to watch.

By situation

One page per situation. The first is live, the others follow one by one.

If you are a biotech CEO and fear running out of cash before the readout.Read the guidance
If you are a biotech CEO and the round is taking longer than the runway.In preparation
If you are a biotech CEO and the bar for the next round has moved up since you last raised.In preparation
If you are a biotech CEO and the readout was bad.In preparation
If you are a biotech CEO and pharma wants the asset after phase 1, and you are not sure you should sell.In preparation
If you are a biotech CEO and have to let people go.In preparation
If you are a biotech CEO and the board is asking whether you are the CEO for the next phase.In preparation
If you are a biotech CEO and the team that got you here is struggling at this size.In preparation
If you are a biotech CEO, alone at seed, and the first investor just said no.In preparation

By conversation

Every guest, newest first. Read the full conversation, or watch it on YouTube.

Sezai Taskin
CEO, ViferaXS
The Moment You Doubt Yourself Is the Moment You Should Stop
Read Watch
Achim Plum
Managing Director of HTGF (High-Tech Gründerfonds), heading Life Science and Chemistry
So, Do We Have a Deal?
Read Watch
Antonin "Tony" de Fougerolles
Founding Chief Scientific Officer of Moderna; board chair and investor
I Shouldn't Be Here: Moderna's First CSO on Making Life Count
Read Watch
Wolfgang Hofmann
CEO, leon-nanodrugs (Munich)
I Can't Not Be Fascinated
Read Watch
Karol Jarzabek
Chief Operating Officer, iOrganBio
We understand only 8 % of Biology
Read Watch
Rosario "Charo" Cestau Murphy
Life sciences commercial executive, Strategic Planning at Untech; formerly Biogen, Vertex and Genzyme
Turning down the obvious path
Read Watch
Dr. Dominik Witzigmann
Co-Founder and President of Nanovation Therapeutics
The Fight for Thousands is not over
Read Watch
Tilmann Bürckstümmer
Co-founder, Myllia Biotechnology
Why This CRISPR Founder Built a Biotech Without VC Money
Read Watch
Jan de Kerpel
Investment Banker, Managing Director Van Lanschot Kempen
The Truth About Biotech Funding Nobody Wants To Admit
Read Watch
Simone Sabbione
Co-founder, Meliodays
FemTech's Trillion-Dollar Question Nobody Asked
Read Watch
Chris Przybyszewski
Serial biotech founder (five companies, including US Biologic)
From Shakespeare to a Biotech Exit
Read Watch
Miguel Coego Rios
CFO of a major biotech company in rare diseases
What Nobody Told Me About Resilience: A CFO's Hard Warning
Read Watch
Klaus Weinberger
CEO, Metaron Diagnostics; co-inventor of one of the first real-time PCR assays
Sabotaged and Still Building
Read Watch
Melissa Simon
Partner, Family Office Wieland Capital
What Investors Look For in Founders: Trust, Femtech & VC Decisions
Read Watch
Dr. Pierre Morgon
Founder of MRGN Advisors; former EVP at CanSino Biologics and VP at Sanofi Pasteur
The Biggest Pain as a Leader? 40 Years of Hard Truths in Biotech
Read Watch
Peter Seufer-Wasserthal
Chairman of the Board at Imperagen and PlanetSmart
Every Chapter Needs a Different You: The Cost of Not Transforming
Read Watch
Zoltan Magyarics
VP of R&D at AOP Health; physician and PhD immunologist
How The Biotech Game Breaks Your Idealism: A Drug Hunter's Confession
Read Watch
Erich Tauber
Co-founder and former CEO, Themis Bioscience
What Nobody Tells You About a Life-Changing Deal
Read Watch
Ilkka Haukijärvi
CEO who built a global vaccine CRO from scratch; former Director of HR at a Finnish university
Winning The Infinite Game: Why Great Leaders Embrace Failure
Read Watch
Jesper Brandgaard
Chairman of LEO Pharma and former CFO of Novo Nordisk (18 years)
Ownership Of The Downside: Elite Leaders Under Pressure
Read Watch
Oliver Schacht
Biotech executive and former public-company CEO; three IPOs; PhD in business
An IPO Is Just The Beginning: The Real Fight Starts When You Go Public
Read Watch
Edwin Moses
Chairman Grey Wolf Therapeutics. Chairman and CEO Ablynx (until 2018)
Feeling Out Of Place. The Story Behind Edwin Moses And How Insecurity Fueled Optimism
Read Watch
Thaminda Ramanayake
CEO Anaveon, CBO CureVac (until 2025)
Leaving Ego Aside: Inside the BioNTech CureVac Deal
Read Watch